A Phase 1B Trial of Cannabidiol for Symptom Management in Kidney Failure
Keywords: cannabidiol, chronic kidney failure, clinical trial, pharmacokinetics, sleep, symptom burden Authors: Brendan Smyth, Taewon Yi, Kristy P. Robledo, Rebecca Gordon, Andrew J. McLachlan, Rachael L. Morton, Iain S. McGregor, Meg Jardine Affiliations: NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia; Department of Renal Medicine, St George Hospital, Kogarah, Australia; Division of Nephrology, University Health Network, Toronto, Ontario, Canada; Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia; Lambert Initiative for Cannabinoid Therapeutics, University of
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join â it's freeAlready a member? Log in